|
Volumn 177, Issue 4, 2006, Pages 2036-2037
|
Comment on "Cutting edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4 +CD25+ T regulatory cells" [4]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BASILIXIMAB;
CD4 ANTIGEN;
INTERLEUKIN 2 RECEPTOR ALPHA;
TRANSCRIPTION FACTOR FOXP3;
INTERLEUKIN 2 RECEPTOR;
MONOCLONAL ANTIBODY;
ANIMAL CELL;
ANTIGEN EXPRESSION;
CD4+ CD25+ T LYMPHOCYTE;
FLUORESCENCE ACTIVATED CELL SORTING;
INJECTION;
LETTER;
MOUSE;
NONHUMAN;
PERIPHERAL LYMPHOCYTE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RAT;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
ANIMAL;
C57BL MOUSE;
CYTOLOGY;
IMMUNOLOGY;
LYMPHOCYTE ACTIVATION;
LYMPHOCYTE DEPLETION;
NOTE;
REGULATORY T LYMPHOCYTE;
ANIMALS;
ANTIBODIES, MONOCLONAL;
LYMPHOCYTE ACTIVATION;
LYMPHOCYTE DEPLETION;
MICE;
MICE, INBRED C57BL;
RATS;
RECEPTORS, INTERLEUKIN-2;
T-LYMPHOCYTES, REGULATORY;
|
EID: 33746879581
PISSN: 00221767
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (40)
|
References (1)
|